Effect of HMG-CoA reductase inhibitors on reduction of panel reactivity

By Ossareh S.   Ghorbani G.   Ghods A.J.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2592-2593

Elsevier

Access to resources Recommend Favorite

Rhabdomyolysis in heart transplant patients on HMG-CoA reductase inhibitors and cyclosporine

By Rodrguez J.A.   Crespo-Leiro M.G.   Paniagua M.J.   Cuenca J.J.   Hermida L.F.   Juffe A.   Castro-Beiras A.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2522-2523

Elsevier

Access to resources Recommend Favorite

Early introduction of HMG-CoA reductase inhibitors could prevent the incidence of transplant coronary artery disease

By Kato T.   Tokoro T.   Namii Y.   Kobayashi T.   Hayashi S.   Yokoyama I.   Morimoto S.   Chan M.   Giannetti N.   Hunt S.A.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 331-333

Elsevier

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 441-453

Bentham Science Publishers

Access to resources Recommend Favorite

Antithrombin III inhibits T- and B-lymphocyte activation in vitro and improves parameters of inflammation in a rat model of acute lung allograft rejection

By Zuo X.J.   Okada Y.   Nicolaidou E.   Toyoda T.   Marchevsky A.   Matloff J.M.   Jordan S.C.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 816-817

Elsevier

Access to resources Recommend Favorite